Non-secosteroidal ligands and modulators

Vitamin D

Volumn , Issue , 2011, Pages 1497-1508

  Stayrook, Keith R ^a   Carson, Matthew W ^b   Ma, Yanfei L ^b   Dodge, Jeffrey A ^b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84884746772     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-381978-9.10078-2     Document Type: Chapter

References (35)

1. Holick M.F. Vitamin D deficiency. N. Engl. J. Med. 2007, 357:266-281.
2. Holick M.F. Calcitropic hormones and the skin: a millennium perspective. J. Cell Biochem. 2003, 88:296-307.
3. R. Bouillon Vitamin D: from photosynthesis, metabolism and action to clinical applications. in: L.L. Degroot, J.L. Jameson (Eds.), Endocrinology, 2001 vol. 2, Fourth ed., pp.1009-1028.
4. Deluca H.F., Cantorna M.T. Vitamin D: its role and uses in immunology. FASEB 2001, 15:2579-2585.
5. Mizwicki M.T., Keidel D., Bula C.M., Bishop J.E., Zanello L.P., Wurtz J., et al. Identification of an alternative ligand-binding pocket in the nuclear vitamin D receptor and its functional importance in 1α,25(OH)2-vitamin D3 signaling. PNAS 2004, 101:12876-12881.
6. Mizwicki M.T., Norman A.W. The vitamin D sterol-vitamin D receptor ensemble model offers unique insights into both genomic and rapid-response signaling. Science Signaling 2009, 2:1-15.
7. Vieth R. Vitamin D toxicity, policy, and science. J. Bone Miner Res. 2007, 22:V64-V68.
8. Carlberg C. Molecular basis of selective activity of vitamin D analogues. J. Cell Biochem. 2003, 88:274-281.
9. Hansdottir H. Raloxifene for older women: a review of the literature. Clin. Interv. Aging 2008, 3(1):45-50.
10. McDonnell D.P., Connor C.E., Wijayaratne A., Chang C.Y., Norris J.D. Definition of the molecular and cellular mechanisms underlying the tissue-selective agonist/antagonist activities of selective estrogen receptor modulators. Recent Prog. Horm. Res. 2002, 57:295-316.
11. Boehm M.F., Fitzgerald P., Zou A., Elgort M.G., Bischoff E.D., Mere L., et al. Novel nonsecosteroidal vitamin D mimics exert VDR-modulating activities with less calcium mobilization than 1,25-dihydroxyvitamin D3. Chem. Biol. 1999, 6:265-275.
12. Teichert A., Arnold L.A., Otieno S., Oda Y., Augustinaite I., Geistlinger T.R., et al. Quantification of the vitamin D receptor - coregulator interaction. Biochemistry 2009, 48(7):1454-1461.
13. Hakamata W., Sato Y., Okuda H., Honzawa S., Saito N., Kishimoto S., et al. (2S,2'R)-Analogue of LG190178 is a major active isomer. Bio. Med. Chem. Lett. 2008, 18:120-123.
14. Hosada S., Tanatani A., Wakabayashi K., Makashima M., Imai K., Miyachi H., et al. Ligands with a 3,3-diphenylpentane skeleton for nuclear vitamin D and androgen receptors: dual activities and metabolic activation. Bioorg. Med. Chem. 2006, 14:5489-5502.
15. Sato M., Lu J., Iturria S., Stayrook K.R., Burris L., Zeng Q.Q., et al. A non-secosteroidal vitamin D receptor ligand with improved therapeutic window of bone efficacy over hypercalcemia. J. Bone Min. Res. 2010, [E-pub]-In press.
16. Ma Y., Khalifa B., Yee Y.K., Lu J., Memezawa A., Savkur R.S., et al. Identification and characterization of noncalcemic, tissue-selective, nonsecosteroidal vitamin D receptor modulators. J. Clin. Invest. 2006, 116:892-904.
17. Polek T.C., Murthy S., Blutt S.E., Boehm M.F., Zou A., Weigel N.L., et al. Novel nonsecosteroidal vitamin D receptor modulator inhibits the growth of LNCaP xenograft tumors in athymic mice without increased serum calcium. Prostate 2001, 49:224-233.
18. Gniadecki R., Serup J. Stimulation of epidermal proliferation in mice with 1-alpha, 25-dihydroxyvitamin D3 and receptor-active 20-epi analogues of 1-alpha, 25-dihydroxyvitamin D3. Biochem. Pharmacol. 1995, 49:621-624.
19. Lutzow-Holm C., De Angelis P., Clausen O.P. Calcitriol and its analog KH 1060 induce similar changes in keratinocyte cell cycle progression after topical application to mouse skin. A bromodeoxyuridine pulse-chase flow cytometric study. J. Investig. Dermatol. Symp. Proc. 1996, 1:54-59.
20. Bouillon R., Okamura W.H., Norman A.W. Structure function relationships in the vitamin D endocrine system. Endocr. Rev. 1995, 16(2):200-257.
21. De Clercq P.J., De Buysser F., Minne G., Schepens W., Vrielynck F., Van Haver D., et al. The development of CD-ring modified analogs of 1α,25-dihydroxyvitamin D. J. Steroid. Biochem. Mol. Biol. 2007, 103(3-5):206-212.
22. Bouillon R., Verlinden L., Eelen G., De Clercq P., Vandewalle M., Mathieu C., et al. Mechanisms for the selective action of vitamin D analogs. J. Ster Biochem. Mol. Bio. 2005, 97(1-2):21-30.
23. Kutner A., Zhao H., Fitak H., Wilson H. Synthesis of Retiferol RAD1 and RAD2, the lead representatives of a new class of des-CD analogs of cholecalciferol. Bioorg. Chem. 1995, 23:22-32.
24. Sabbe K., D'Hallewyn P., De Clercq P.J., Vandewalle M. Synthesis of CD-ring modified 1α,25-dihydroxy vitamin D analogues: E-ring analogues. Bioorg. Med. Chem. Lett. 1996, 6:1697-1702.
25. 3. Organic Let. 2006, 8:4247-4250.
26. 3. Tetrahedron. Lett. 2009, 50:4174-4177.
27. 3 (2MD): synthesis and biological evaluation. Bioorg. and Med. Chem. 2009, 17:1747-1763.
28. Verstuyf A., Verlinden L., Van Etten E., Shi L., Wu Y., D'Halleweyn C., et al. Biological activity of CD-ring modified 1α,25-dihydroxy vitamin D analogues: C-ring and five-membered D-ring analogues. J. Bone Miner. Res. 2000, 15(2):237-252.
29. Verstuyf A., Verlinden L., Van Baelen H., Sabbe K., D'Hallewyn C., De Clercq P., et al. The biological activity of nonsteroidal vitamin D analogs lacking both the C- and D-rings. J. Bone Miner. Res. 1998, 13:549-558.
30. Peräkylä M., Malinen M., Herzig K.H., Carlberg C. Gene regulatory potential of nonsteroidal vitamin D receptor ligands. Mol. Endocrinol 2005, 19:2060-2073.
31. Chen F., Su Q., Torrent M., Wei N., Peekhaus N., McMasters D., et al. Identification and characterization of a novel nonsecosteroidal vitamin D receptor ligand. Drug. Dev. Res. 2007, 68:51-60.
32. Makishima M., Lu T.L., Xie W., Whitfield G.K., Domoto H., Evans R.M., et al. Vitamin D receptor as an intestinal bile acid sensor. Science 2002, 296(5571):1313-1316.
33. Ishizawa M., Matsunawa M., Adachi R., Uno S., Ikeda K., Masuno H., et al. Lithocholic acid derivatives act as selective vitamin D receptor modulators without inducing hypercalcemia. J. Lipid Res. 2008, 49(4):763-772.
34. Haussler M.R., Haussler C.A., Bartik L., Whitfield G.K., Hsieh J.C., Slater S., et al. Vitamin D receptor: molecular signaling and actions of nutritional ligands in disease prevention. Nutr. Rev. 2009, 66:S98-S112.
35. Mizwicki M.T., Menegaz D., Yaghmaei S., Henry H.L., Norman A.W. A molecular description of ligand binding to the two overlapping binding pockets of the nuclear vitamin D receptor (VDR): structure-function implications. J. Steroid. Biochem. Mol. Biol. [E-pub] 2010, In press.